Study of CAbozantinib in Combination With AtezolizumaB for Muscle-Invasive BladdEr Cancer (ABATE)

Condition:   Bladder Cancer Interventions:   Drug: Cabozantinib;   Drug: Atezolizumab;   Procedure: Cystectomy Sponsors:   Deepak Kilari;   Exelixis;   Genentech, Inc.;   Medical College of Wisconsin Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials